Gene therapy methods using bone marrow-derived cells expressing blood clotting factors
Patent Number: 6410015
Date of First Priority Issue: Tuesday November 12th, 1996
Date Issued: Tuesday June 25th, 2002
Assignee: University of Southern California (Los Angeles, CA)
Inventors: Gordon, Erlinda Maria (Glendale, CA); Hall, Frederick L. (Glendale, CA); Anderson, W. French (San Marino, CA)
From Class: Use
Comments: No comments
This patent covers hematopoietic stem cells that are gene transfected with various clotting factors. In some embodiments the stem cells have a preferntially affinity towards injured tissue.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.